AI Co-scientist：多代理 AI 系統如何重新定義科學發現流程 2026 🐯

Anthropic News 觸發的技術問題

從 Anthropic News 的 Claude Design（2026-04-17）觸發：「Claude Design 如何協助協作創作設計、原型、幻燈片與單頁文件，從而降低創作門檻？」 這引發的跨域思考：當 AI 從純文本協作走向多模態協作，多代理系統的協同模式 與 科學發現流程重構 是否存在結構性相似？

AI Co-scientist 核心架構

Google DeepMind 的 AI Co-scientist 系統是一個多代理 AI 系統，旨在作為科學家的協作工具。其核心特徵：

• 六個專業智能體：Generation（生成）、Reflection（反思）、Ranking（排序）、Evolution（演化）、Proximity（靠近）、Meta-review（元評審），模仿科學方法論
• 測試時間計算擴展：利用 Elo 自評估指標，更高 Elo 分數與 GPQA 準確率呈正相關
• 自我改進循環：通過自我對抗（self-play）生成假設、排名競賽、演化過程三個關鍵步驟

技術深挖：測試時間計算與 Elo 指標

AI Co-scientist 通過測試時間計算擴展（test-time compute scaling）實現遞歸推理與改進：

1. 自我對抗科學辯論：生成假設
2. 排名競賽：假設比較
3. 演化過程：質量改進

系統通過Elo 自評估指標衡量輸出質量，並與 GPKA 準確率進行驗證。實驗顯示，更高 Elo 分數對應更高 GPKA 準確率，證明測試時間計算擴展在科學推理中的有效性。

真實場景驗證：三個關鍵應用

AML 藥物重定位（急性骨髓性白血病）

• 挑戰：新藥開發越來越耗時和昂貴（Eroom’s law）
• 方法：AI Co-scientist 輔助預測藥物重定位機會
• 驗證：通過計算生物學、臨床醫生反饋與體外實驗驗證
• 結果：提出新的 AML 重定位候選藥物，在多個 AML 細胞系中抑制腫瘤存活，在臨床相關濃度下有效

肝纖維化靶點發現

• 挑戰：靶點發現複雜，假設選擇效率低
• 方法：AI Co-scientist 提出假設、生成實驗協議
• 驗證：人類肝臟類器官中的表觀遺傳靶點，具有顯著抗纖維化活性
• 結果：識別出基於預臨床證據的表觀遺傳靶點

抗菌耐藥性機制解析

• 挑戰：細菌基因轉移進化機制的理解涉及複雜分子機理
• 方法：專家研究人員指導 AI Co-scientist 探索尚未公開發布的主題
• 驗證：預測細胞衣形成噬菌體誘導染色體島的機制
• 結果：生成關於細菌基因轉移進化機制的假設，為理解抗菌耐藥性提供新視角

與 Claude Design 的跨域對比

維度	AI Co-scientist	Claude Design
協作模式	多代理系統，六個專業智能體協同	Claude 輔助協作創作視覺工作
輸出目標	科學假設、研究計畫、實驗協議	設計、原型、幻燈片、單頁文件
驗證方式	Elo 自評估 + GPKA 準確率驗證	人類審查與反饋
測試時間	計算擴展驅動推理品質提升	未公開測試時間計算數據
創新性	自我對抗科學辯論	未公開自我改進機制

關鍵洞察：AI Co-scientist 與 Claude Design 都在協作創作領域，但 AI Co-scientist 的多代理架構使其能夠自我改進，而 Claude Design 專注於人機協作創作流程。

部署門檻與可擴展性

• 計算需求：測試時間計算擴展需要更多推理時間
• Elo 自評估：需要大量假設生成與排名競賽
• 專家介入：三個場景均涉及專家指導與驗證
• 成本考量：測試時間計算的延展性取決於可用的計算資源

部署邊界：對於高資源環境（如研究實驗室、大型科技公司），AI Co-scientist 可顯著縮短假設生成與驗證週期；對於資源受限環境，建議採用低計算、高品質的推理模式。

結論：科學發現流程的 AI 重構

AI Co-scientist 展示了多代理系統在科學發現中的潛力：

1. 假設生成：自我對抗科學辯論
2. 假設驗證：Elo 自評估與 GPKA 驗證
3. 假設優化：演化過程與專家反饋

與 Claude Design 的協作創作形成對比：多代理自我改進系統 vs 人機協作創作流程。這表明，隨著 AI 系統從文本協作走向多模態協作，多代理架構將成為重構複雜工作流程（無論是科學發現還是創意創作）的關鍵技術。

下一步：觀察 Anthropic 是否推出類似的多代理協作系統，以及 Google DeepMind 是否將 AI Co-scientist 擴展到更多科學領域。

---

參考來源：

• Google Research: Accelerating scientific breakthroughs with an AI co-scientist
• Anthropic News: Introducing Claude Design by Anthropic Labs (2026-04-17)

#AI Co-scientist: How multi-agent AI systems are redefining the scientific discovery process 2026 🐯

Technical issues triggered by Anthropic News

Triggered from Claude Design (2026-04-17) of Anthropic News: “How does Claude Design assist in the collaborative creation of designs, prototypes, slides, and single-page documents, thereby lowering the threshold for creation?” The cross-domain thinking this triggered: When AI moves from pure text collaboration to multi-modal collaboration, is there any structural similarity between collaboration mode of multi-agent systems and scientific discovery process reconstruction?

AI Co-scientist core architecture

Google DeepMind’s AI Co-scientist system is a multi-agent AI system designed to serve as a collaboration tool for scientists. Its core features:

• Six professional agents: Generation, Reflection, Ranking, Evolution, Proximity, Meta-review, imitating scientific methodology
• Test Time Calculation Extension: Leveraging the Elo self-assessment metric, higher Elo scores are positively correlated with GPQA accuracy
• Self-improvement cycle: Three key steps of hypothesis generation, ranking competition, and evolution process through self-play

Technical Digging: Test Time Calculation and Elo Indicator

AI Co-scientist implements recursive reasoning and improvement through test-time compute scaling:

1. Self-vs. Science Debate: Generating Hypotheses
2. Ranking Contest: Hypothetical Comparison
3. Evolutionary Process: Quality Improvement

The system measures output quality through the Elo self-evaluation metric and verifies it with GPKA accuracy. Experiments show that higher Elo scores correspond to higher GPKA accuracy, demonstrating the effectiveness of Test Time Computation Extension in scientific reasoning.

Real-life scenario verification: three key applications

AML Drug Repositioning (Acute Myelogenous Leukemia)

• Challenge: New drug development is increasingly time-consuming and expensive (Eroom’s law)
• Method: AI Co-scientist assists in predicting drug repositioning opportunities
• Validation: Verified through computational biology, clinician feedback and in vitro experiments
• RESULTS: Novel AML repositioning drug candidate is presented, inhibits tumor survival in multiple AML cell lines, and is effective at clinically relevant concentrations

Target discovery in liver fibrosis

• Challenges: Target discovery is complex and hypothesis selection efficiency is low
• Method: AI Co-scientist proposes hypotheses and generates experimental protocols
• Validation: Epigenetic target in human liver organoids with significant anti-fibrotic activity
• Results: Epigenetic targets identified based on preclinical evidence

Analysis of Antimicrobial Resistance Mechanisms

• Challenge: Understanding the evolutionary mechanism of bacterial gene transfer involves complex molecular mechanisms
• Method: Expert researchers guide AI Co-scientists in exploring topics not yet publicly available
• Validation: Predict the mechanism of cell coat formation of phage-induced chromosomal islands
• Results: Generate hypotheses about the evolutionary mechanism of bacterial gene transfer, providing a new perspective for understanding antimicrobial resistance

Cross-domain comparison with Claude Design

Dimensions	AI Co-scientist	Claude Design
Collaboration Mode	Multi-agent system, six professional agents collaborate	Claude assists in collaborative visual creation
Output Target	Scientific hypothesis, research plan, experimental protocol	Design, prototype, slides, one-page document
Verification method	Elo self-assessment + GPKA accuracy verification	Human review and feedback
Test time	Computational expansion drives inference quality improvement	Undisclosed test time calculation data
Innovative	Self-confrontation scientific debate	Undisclosed self-improvement mechanism

Key Insight: AI Co-scientist and Claude Design are both in the field of collaborative creation, but AI Co-scientist’s multi-agent architecture enables self-improvement, while Claude Design focuses on human-machine collaboration creation processes.

Deployment threshold and scalability

• Compute Requirements: Test time calculation scaling requires more inference time
• Elo Self-Assessment: Requires extensive hypothesis generation and ranking competition
• Expert intervention: All three scenarios involve expert guidance and verification
• Cost Consideration: The scalability of test time calculations depends on the available computing resources

Deployment Boundary: For high resource environments (such as research laboratories, large technology companies), AI Co-scientist can significantly shorten the hypothesis generation and verification cycle; for resource-constrained environments, it is recommended to use low calculation, high quality inference mode.

Conclusion: AI Reconstruction of the Scientific Discovery Process

AI Co-scientist demonstrates the potential of multi-agent systems in scientific discovery:

1. Hypothesis Generation: Self-confrontation Scientific Debate
2. Hypothesis Verification: Elo self-assessment and GPKA verification
3. Hypothesis Optimization: Evolution Process and Expert Feedback

Contrast this with Claude Design’s collaborative creation: Multi-agent self-improving system vs Human-machine collaborative creation process. This shows that as AI systems move from text collaboration to multimodal collaboration, multi-agent architecture will become a key technology for reconstructing complex workflows, whether it is scientific discovery or creative creation.

Next steps: Watch to see if Anthropic launches a similar multi-agent collaboration system, and if Google DeepMind expands AI Co-scientist into more scientific fields.

---

Reference source:

• Google Research: Accelerating scientific breakthroughs with an AI co-scientist
• Anthropic News: Introducing Claude Design by Anthropic Labs (2026-04-17)